MAX
Company Analysis Coloplast A/S
1. Summary
Advantages
- Price (6.92 $) is less than fair price (11.52 $)
- Dividends (3.17%) are higher than the sector average (1.68%).
- The stock's return over the last year (-26.46%) is higher than the sector average (-43.8%).
- The company's current efficiency (ROE=21.2%) is higher than the sector average (ROE=14.81%)
Disadvantages
- Current debt level 46.81% has increased over 5 years from 8.23%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Coloplast A/S | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.6% | -5.5% | -1.6% |
| 90 days | -21.1% | -23.3% | -2.5% |
| 1 year | -26.5% | -43.8% | 11.7% |
CLPBY vs Sector: Coloplast A/S has outperformed the "Healthcare" sector by 17.34% over the past year.
CLPBY vs Market: Coloplast A/S has significantly underperformed the market by -38.13% over the past year.
Stable price: CLPBY is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CLPBY with weekly volatility of -0.51% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (6.92 $) is lower than the fair price (11.52 $).
Price significantly below the fair price: The current price (6.92 $) is 66.5% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (4.55) is lower than that of the sector as a whole (40.45).
P/E vs Market: The company's P/E (4.55) is lower than that of the market as a whole (38.45).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (0.97) is lower than that of the sector as a whole (3.61).
P/BV vs Market: The company's P/BV (0.97) is lower than that of the market as a whole (4.32).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0.59) is lower than that of the sector as a whole (3.93).
P/S vs Market: The company's P/S indicator (0.59) is lower than that of the market as a whole (12.17).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (5.26) is lower than that of the sector as a whole (16.43).
EV/Ebitda vs Market: The company's EV/Ebitda (5.26) is lower than that of the market as a whole (24.93).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -5.8% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-5.8%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-39.75%).
6.4. ROE
ROE vs Sector: The company's ROE (21.2%) is higher than that of the sector as a whole (14.81%).
ROE vs Market: The company's ROE (21.2%) is lower than that of the market as a whole (50.36%).
6.6. ROA
ROA vs Sector: The company's ROA (7.07%) is lower than that of the sector as a whole (7.7%).
ROA vs Market: The company's ROA (7.07%) is lower than that of the market as a whole (35.27%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (24.19%) is higher than that of the sector as a whole (14.62%).
ROIC vs Market: The company's ROIC (24.19%) is higher than that of the market as a whole (10.89%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.17% is higher than the average for the sector '1.68%.
8.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.17% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 3.17% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (136.35%) are at an uncomfortable level.
Based on sources: porti.ru
